Search
Biomx Inc
PHGEAdd to Watchlist
0.681USD
-0.039-5.42%
Close 09-10 16:00（ET）
23.42MMarket Cap
LossP/E TTM
More Details of Biomx Inc Company
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).
Biomx Inc Profile
Ticker SymbolPHGE
Company nameBiomx Inc
IPO dateDec 18, 2018
CEOSolomon (Jonathan Eitan)
Number of employees52
Security typeOrdinary Share
Fiscal year-endDec 18
Address22 Einstein St.
CityNESS-ZIONA
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryIsrael
Postal code7414003
Phone972723942377
Websitehttps://www.biomx.com/
Ticker SymbolPHGE
IPO dateDec 18, 2018
CEOSolomon (Jonathan Eitan)
Company Executives of Biomx Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Reuven Yeganeh
Mr. Reuven Yeganeh
Independent Director
Independent Director
1.50K
+66.67%
Ms. Liat Bidas
Ms. Liat Bidas
Independent Director
Independent Director
1.50K
+66.67%
Mr. Guy Arieli
Mr. Guy Arieli
Independent Director
Independent Director
1.50K
+66.67%
Mr. Reuven Yeganeh
Mr. Reuven Yeganeh
Independent Director
Independent Director
1.50K
+66.67%
Ms. Liat Bidas
Ms. Liat Bidas
Independent Director
Independent Director
1.50K
+66.67%
Mr. Guy Arieli
Mr. Guy Arieli
Independent Director
Independent Director
1.50K
+66.67%
Mr. Ben Cohen
Mr. Ben Cohen
IR Contact Officer
IR Contact Officer
--
--
Mr. Shaked Ran
Mr. Shaked Ran
Independent Director
Independent Director
--
--
Mr. David Rokach
Mr. David Rokach
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
--
--
Mr. Amir Shalom
Mr. Amir Shalom
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Reuven Yeganeh
Mr. Reuven Yeganeh
Independent Director
Independent Director
1.50K
+66.67%
Ms. Liat Bidas
Ms. Liat Bidas
Independent Director
Independent Director
1.50K
+66.67%
Mr. Guy Arieli
Mr. Guy Arieli
Independent Director
Independent Director
1.50K
+66.67%
Mr. Reuven Yeganeh
Mr. Reuven Yeganeh
Independent Director
Independent Director
1.50K
+66.67%
Ms. Liat Bidas
Ms. Liat Bidas
Independent Director
Independent Director
1.50K
+66.67%
Mr. Guy Arieli
Mr. Guy Arieli
Independent Director
Independent Director
1.50K
+66.67%
FAQs
Who are the top five shareholders of Biomx Inc?
The top five shareholders of Biomx Inc are: Mr. Reuven Yeganeh
How many institutions hold shares of Biomx Inc (PHGE)?
As of 2026Q1, 36 institutions hold shares of Biomx Inc, with a combined market value of approximately 319.22K, accounting for 6.63% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -512775.00.